April 2022 newsletter
Sneak peek at Flare™ V6 for medicinal chemists This sneak peek gives insight to just a few of the new features ...
Protein-ligand binding affinity is one of the most useful metrics for predicting drug activity. We present one of the most promising approaches to predicting non-covalent interactions, compare it to Cresset's existing methodology, and discuss what this means for the future of Cresset software development.
Explore some of the new features and enhancements in the Flare V5 ligand and structure-based design platform that enable research chemists to discover new small molecules more efficiently and effectively.
The Python API in Flare is most powerful to drug discovery teams when used to connect to external systems, such as Torx™, either to push out results or pull in external data for processing with Flare's extensive scientific methods.
Martin Slater, Director of Consulting Services, walks through the processes that he and his team of CADD scientists follow when working with pharmaceutical, agrochemical and flavor and fragrance organizations to deliver on their corporate objectives.
The article explores the growing trends of computer-aided drug discovery and outsourcing in the pharmaceutical industry. It features Cresset's comprehensive molecule design platform, Flare, and highlights the work that the Cresset Discovery Services team does to support organizations to deliver on their discovery projects.